BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7486161)

  • 1. Technique for quantifying the duration of intravenous anesthetic effect.
    Bailey JM
    Anesthesiology; 1995 Nov; 83(5):1095-103. PubMed ID: 7486161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic parameters relevant to recovery from opioids.
    Youngs EJ; Shafer SL
    Anesthesiology; 1994 Oct; 81(4):833-42. PubMed ID: 7943834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measured context-sensitive half-times of remifentanil and alfentanil.
    Kapila A; Glass PS; Jacobs JR; Muir KT; Hermann DJ; Shiraishi M; Howell S; Smith RL
    Anesthesiology; 1995 Nov; 83(5):968-75. PubMed ID: 7486182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from opioid anesthesia: the clinical implication of context-sensitive half-times.
    Schraag S; Mohl U; Hirsch M; Stolberg E; Georgieff M
    Anesth Analg; 1998 Jan; 86(1):184-90. PubMed ID: 9428876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness.
    Vuyk J; Mertens MJ; Olofsen E; Burm AG; Bovill JG
    Anesthesiology; 1997 Dec; 87(6):1549-62. PubMed ID: 9416739
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting.
    Ahonen J; Olkkola KT; Salmenperä M; Hynynen M; Neuvonen PJ
    Anesthesiology; 1996 Dec; 85(6):1246-52. PubMed ID: 8968170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, pharmacodynamics, and rational opioid selection.
    Shafer SL; Varvel JR
    Anesthesiology; 1991 Jan; 74(1):53-63. PubMed ID: 1824743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions.
    Wiczling P; Bieda K; Przybyłowski K; Hartmann-Sobczyńska R; Borsuk A; Matysiak J; Kokot ZJ; Sobczyński P; Grześkowiak E; Bienert A
    Biopharm Drug Dispos; 2016 Jul; 37(5):252-63. PubMed ID: 26990035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol.
    Vuyk J
    J Clin Anesth; 1997 Sep; 9(6 Suppl):23S-26S. PubMed ID: 9278851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of dose profile of remifentanil with computer simulation: comparative study with fentanyl and alfentanyl].
    Gambús PL; Schnider TW; Minto CF
    Rev Esp Anestesiol Reanim; 1998 Oct; 45(8):317-25. PubMed ID: 9847642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.
    Hughes MA; Glass PS; Jacobs JR
    Anesthesiology; 1992 Mar; 76(3):334-41. PubMed ID: 1539843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.
    Johnson KB; Egan TD; Kern SE; McJames SW; Cluff ML; Pace NL
    Anesthesiology; 2004 Sep; 101(3):647-59. PubMed ID: 15329589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern concepts in pharmacokinetics of intravenous anesthetics].
    Heidegger T; Minto CF; Schnider TW
    Anaesthesist; 2004 Jan; 53(1):95-110. PubMed ID: 14994741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
    Bienert A; Wiczling P; Zaba C; Zaba Z; Wolc A; Marciniak R; Grześkowiak E; Kusza K
    Arzneimittelforschung; 2011; 61(10):545-52. PubMed ID: 22164962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketofol simulations for dosing in pediatric anesthesia.
    Coulter FL; Hannam JA; Anderson BJ
    Paediatr Anaesth; 2014 Aug; 24(8):806-12. PubMed ID: 24666723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia.
    Zaba Z; Bienert A; Drobnik L; Dyderski S; Kusza K
    CNS Drugs; 2007; 21(2):165-71. PubMed ID: 17284097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propofol context-sensitive decrement times in children.
    Morse JD; Cortinez LI; Meneely S; Anderson BJ
    Paediatr Anaesth; 2022 Mar; 32(3):396-403. PubMed ID: 34971456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.
    Johnson KB; Egan TD; Kern SE; White JL; McJames SW; Syroid N; Whiddon D; Church T
    Anesthesiology; 2003 Aug; 99(2):409-20. PubMed ID: 12883414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery.
    Ahonen J; Olkkola KT; Hynynen M; Seppälä T; Ikävalko H; Remmerie B; Salmenperä M
    Br J Anaesth; 2000 Oct; 85(4):533-40. PubMed ID: 11064610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.